XW Laboratories Inc., a China headquartered clinical-stage biopharmaceutical company pioneering the discovery of novel s...
Prestige BioPharma has announced positive top-line results from a Phase III global clinical trial (Troika) evaluati...
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to marke...
Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the t...
Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, on 21 June 2019, announc...
Edesa Biotech, a clinical-stage biopharmaceutical company has reported that the U.S. Food and Drug Administration h...
Boehringer Ingelheim and Eli Lilly and Company have announced results of a new post-hoc analysis of data from the EMPA-R...
Reistone Biopharma Company Limited (Reistone), on 14 June 2019, announced dosing of the first patient in their Phase II ...
Lumosa Therapeutics, on 13 June 2019, announced that the company is ready to commence the Phase 2 proof of concept (PoC)...
Sinovant Sciences announced on 13 June 2019, that its Clinical Trial Application (CTA) for lefamulin has been accepted b...
Terns Pharmaceuticals, Inc. and Shanghai Tuo Zhen Biological Technology Co., Ltd., on 13 June 2019, announced the launch...
Dr. Reddy’s has announced positive topline results from its Phase 2b study of PPC-06 (formerly referred to as...
Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for can...
CStone Pharmaceuticals has announced that it has received approval to initiate clinical development in C...
Genentech, a member of the Roche Group has announced that the Phase III BLOCKSTONE study, conducted by Shionogi &am...
Saluda Medical Pty Limited ("Saluda Medical") has announced data from two clinical studies evaluating the performance of...
Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines...
Pi Therapeutics, a company dedicated to the development of novel modulators of protein degradation for cancer has announ...
